RxDoctor Payments Data

Carmen Fotso, MD

Family Medicine · West Dundee, ILNPI 1336122902

Payments from drug & device makers

$1,163in general payments, 2019–2025

Across 22 payments — averaging $52.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$366
  • Lilly USA, LLC$267
  • Edwards Lifesciences$172
  • GSK$139
  • Medtronic$110
  • Johnson & Johnson$65
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$1,163100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk9$366
Lilly USA, LLC4$267
Edwards Lifesciences1$172
GSK3$139
Medtronic1$110
Johnson & Johnson(2 entities)2$65
Dexcom, Inc.1$26
Pfizer1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,163 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$75,916
Medicare patients
158
Services billed
1,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$70,489
JardianceEmpagliflozin43$51,901
MounjaroTirzepatide26$28,224
JanuviaSitagliptin Phosphate15$24,433
TrulicityDulaglutide22$24,230
EliquisApixaban16$20,298
TradjentaLinagliptin12$16,835
Advair HfaFluticasone Propion/Salmeterol25$10,719
XareltoRivaroxaban16$9,035
Breo ElliptaFluticasone/Vilanterol20$7,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,927
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$6,552
Atorvastatin Calcium435$4,677
Incruse ElliptaUmeclidinium Bromide13$4,473
Omeprazole170$2,194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$366$70,48962 claims
Lilly USA, LLCMounjaro, Trulicity$267$52,45448 claims
PfizerEliquis$19$20,29816 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$139$19,17544 claims
Johnson & JohnsonXarelto$65$9,03516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in West Dundee

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →